top of page

Third Harmonic Bio is nearing an IND submission to put a new oral KIT inhibitor into the clinic

  • Mar 4, 2024
  • 1 min read

CEO Natalie Holles describes how learnings from a setback from the company's first asset have resulted in a new program that she believes can have wide utility in multiple mast cell mediated inflammatory conditions.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

bottom of page